Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.31 |
| ▸ | XIAP | P98170 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2650844 | 0.92 | SLC2A1 (0.34) | SMN1; SMN2SLC2A1MEN1NPC1RAB9A | |
| SCHEMBL1341862 | 0.90 | SLC2A1 (0.37) | SMN1; SMN2SLC2A1MEN1NPC1RAB9A | |
| SCHEMBL1340323 | 0.89 | KMT2A (0.36) | SMN1; SMN2SLC2A1XIAPMEN1NPC1 | |
| SCHEMBL1340324 | 0.86 | SLC2A1 (0.37) | SMN1; SMN2SLC2A1XIAPMEN1NPC1 | |
| SCHEMBL1341860 | 0.86 | KMT2A (0.35) | SMN1; SMN2MEN1NPC1RAB9AKMT2A | |
| SCHEMBL2652270 | 0.85 | GCK (0.35) | GRM4 | |
| SCHEMBL2649924 | 0.83 | GCK (0.35) | SMN1; SMN2MEN1NPC1RAB9AKMT2A | |
| SCHEMBL1340874 | 0.82 | KDM4E (0.38) | SMN1; SMN2SLC2A1NPC1RAB9A | |
| SCHEMBL1341722 | 0.81 | SMN1; SMN2 (0.39) | SMN1; SMN2MEN1NPC1RAB9AKMT2A | |
| SCHEMBL1343475 | 0.80 | GCK (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1531815-A1 | GLUCOKINASE ACTIVATORS | NOVO NORDISK A/S (DK) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004002481-A1 | ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS | NOVO NORDISK A/S (DK) | 2004-01-08 | — | — | WO | disclosed |